Showing 49–68 of 68 results

Olanib 150 mg Tablet

Molecule : OlaparibManufacturer : Everest Pharma

Olanib 50 mg Capsule

Molecule : OlaparibManufacturer : Everest Pharma

Palboxen 125 mg Capsule

Molecule : PalbociclibManufacturer : Everest Pharma

Palnat 100 mg Capsule

Molecule : PalbociclibManufacturer : Natco Pharma

Palnat 125 mg Capsule

Molecule : PalbociclibManufacturer : Natco Pharma

Perjeta 420 mg Injection

Molecule : PertuzumabManufacturer : Roche

Phesgo Injection

Molecule : PertuzumabManufacturer : Roche

Ribotix 200 mg Tablet

Molecule : RibociclibManufacturer : Beacon Pharma

Tecentriq 1200 mg Injection

Molecule : AtezolizumabManufacturer : Roche

Trodelvy 180 mg Vial

Molecule : Sacituzumab GovitecanManufacturer : Gilead

Truqap 200 mg Tablet

Molecule : CapivasertibManufacturer : Astrazeneca

Tucanat 150 mg Tablet

Molecule : TucatinibManufacturer : Natco Pharma

Tucaxen 150 mg Tablet

Molecule : TucatinibManufacturer : Everest Pharma

Tukysa 150 mg Tablet

Molecule : TucatinibManufacturer : Seagen
(1)

Tykerb 250 mg Tablet

Molecule : LapatinibManufacturer : Novartis

Verzenio 50 mg Tablet

Molecule : AbemaciclibManufacturer : Eli Lilly And Company

Vinelbine 10 mg Injection

Molecule : VinorelbineManufacturer : Fresenius Kabi

Vinelbine 50 mg Injection

Molecule : VinorelbineManufacturer : Fresenius Kabi

Vitrakvi 100 mg Capsule

Molecule : LarotrectinibManufacturer : Bayer Zydus Pharma Pvt Ltd

Xtane 25 mg Tablet

Molecule : ExemestaneManufacturer : Natco Pharma

Related Posts:

FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option

Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve

READ MORE »
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026.n n Metastatic breast cancer (mBC)

READ MORE »
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases

Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue

READ MORE »